Tag: molecule design
Chai Discovery raises $400 million Series C for AI drug design
The startup behind AI molecule models used by Lilly, Novartis and Pfizer hits a $3.8 billion valuation.
The startup behind AI molecule models used by Lilly, Novartis and Pfizer hits a $3.8 billion valuation.